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Shan et al. report that the selective
sequestration of the H3K9
methyltransferase Clr4 by H3K9M at
heterochromatin requires an additional
histone modification, H3K14ub. In vitro
characterization reveals that H3K14ub
changes the kinetics of the Clr4-H3K9M
interaction. This selective sequestration
model reconciles previous discrepancies
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https://doi.org/10.1016/j.celrep.2021.109137SUMMARYOncogenic histone lysine-to-methionine mutations block the methylation of their corresponding lysine resi-
dues on wild-type histones. One attractive model is that these mutations sequester histone methyltrans-
ferases, but genome-wide studies show that mutant histones and histone methyltransferases often do not
colocalize. Using chromatin immunoprecipitation sequencing (ChIP-seq), here, we show that, in fission
yeast, even though H3K9M-containing nucleosomes are broadly distributed across the genome, the histone
H3K9 methyltransferase Clr4 is mainly sequestered at pericentric repeats. This selective sequestration of
Clr4 depends not only on H3K9M but also on H3K14 ubiquitylation (H3K14ub), a modification deposited
by a Clr4-associated E3 ubiquitin ligase complex. In vitro, H3K14ub synergizes with H3K9M to interact
with Clr4 and potentiates the inhibitory effects of H3K9M on Clr4 enzymatic activity. Moreover, binding ki-
netics show that H3K14ub overcomes the Clr4 aversion to H3K9M and reduces its dissociation. The selective
sequestrationmodel reconciles previous discrepancies and demonstrates the importance of protein-interac-
tion kinetics in regulating biological processes.INTRODUCTION
Recent sequencing analyses have found that histone lysine-to-
methionine mutations are associated with distinct types
of cancers. For example, more than 80% of diffuse intrinsic
pontine gliomas contain a somatic K27M mutation in histone
H3.3 or H3 (Schwartzentruber et al., 2012; Sturm et al., 2012;
Wu et al., 2012), and more than 90% of chondroblastomas and
a subset of head and neck squamous cell carcinomas contain a
K36M mutation in histone H3.3 or H3 (Behjati et al., 2013;
Papillon-Cavanagh et al., 2017). These mutations transformThis is an open access article under the CC BY-Nnormal cells into tumor-like states, suggesting that they have crit-
ical roles in tumorigenesis (Chan et al., 2013a; Fang et al., 2016;
Funato et al., 2014; Lu et al., 2016; Mohammad et al., 2017).
Introducing histones containing lysine-to-methionine muta-
tions, such as H3K9M, H3K27M, and H3K36M, into mammalian
or yeast cells all reduced methylation of their corresponding
lysine residues on wild-type histones (Brumbaugh et al., 2019;
Chan et al., 2013a, 2013b; Fang et al., 2016; Herz et al., 2014;
Lewis et al., 2013; Lu et al., 2016; Mohammad et al., 2017; Piunti
et al., 2017; Sarthy et al., 2020; Shan et al., 2016; Stafford et al.,




OPEN ACCESSdominant fashion and, possibly, through similar mechanisms.
Oneof themost attractivemodels throughwhich thesemutations
regulate global histone methylation is the sequestration of his-
tone methyltransferases. Such a hypothesis is supported by
interaction assays showing that K-to-M mutations enhanced
the binding between histones and their methyltransferases both
in vitro and in vivo (Bender et al., 2013; Chan et al., 2013a; Fang
et al., 2016; Jayaram et al., 2016; Justin et al., 2016; Lu et al.,
2016; Shan et al., 2016; Zhang et al., 2017). However, recent
studies of the H3.3K27Mmutation in vivo are not entirely consis-
tentwith thesequestrationmodel. For example, chromatin immu-
noprecipitation sequencing (ChIP-seq) analyses of cancer cells
expressing H3.3K27M found that, although the H3K27 methyl-
transferase PRC2 levels are higher at a set of poised enhancers
that also contains H3.3K27M, most genomic loci containing
high levels of H3.3K27M show no association with PRC2 (Fang
et al., 2018; Piunti et al., 2017; Sarthy et al., 2020). Moreover,
mass spectrometry analyses of proteins associated with
H3.3K27M-containing nucleosomes did not detect higher levels
of PRC2 than wild-type nucleosomes did (Herz et al., 2014). It
is, therefore, critical to resolve these discrepancies to better un-
derstand the function of these mutations in tumorigenesis.
We have previously established a model of the H3K9M muta-
tion in fission yeast (Shan et al., 2016). In this organism, histone
H3K9methylation is required for the formation of heterochromat-
in at repetitive DNA elements (Grewal and Jia, 2007), and there
are three copies of the histone H3 genes (hht1+, hht2+, and
hht3+) with identical protein sequences. We have generated
FLAG-tagged versions of wild-type and K9M mutant at the
endogenous hht3+ locus. Western blot analysis with a histone
H3 antibody indicates that the mutant histone is expressed at
lower levels than endogenous histone H3 is (Figure 1A). We
found that H3K9M dominantly blocks H3K9 methylation at major
heterochromatin domains (Shan et al., 2016). Moreover, the
H3K9M mutation enhances the interaction between the H3K9
methyltransferase Clr4 and histone H3 tail peptide in vitro, and
that mutation results in higher levels of Clr4 at heterochromatin
in vivo, leading to a model of H3K9M sequestering Clr4 to block
H3K9 methylation (Shan et al., 2016).
In this study, we used that fission yeast H3K9M model to
further examine whether the H3K9M mutation functions through
the sequestration of Clr4. We found that, even though the
H3K9M mutant histone is broadly distributed across the
genome, Clr4 is only sequestered at heterochromatin, suggest-
ing that additional mechanisms at heterochromatin might facil-
itate the sequestration of Clr4 by H3K9M. Clr4 associates with
an E3 ubiquitin ligase complex, composed of Cul4, Rik1, Raf1,
and Raf2 (Hong et al., 2005; Horn et al., 2005; Jia et al., 2005),
to form CLRC. CLRC ubiquitylates histone H3K14 (H3K14ub),
and H3K14ub is associated with H3K9me3 containing hetero-
chromatin, but not H3K4me3 containing euchromatin (Oya
et al., 2019; Stirpe et al., 2020). We found that mutating either
CLRC or H3K14 abolished the sequestration of Clr4 by
H3K9M. Furthermore, we show that in vitro, H3K9M
works synergistically with H3K14ub to interact with Clr4, and
H3K14ub potentiates the inhibitory effects of H3K9M. These re-
sults demonstrate that H3K14ub is critical for the sequestration
of Clr4 by H3K9M.2 Cell Reports 35, 109137, May 18, 2021RESULTS AND DISCUSSION
To further examine the mechanism by which H3K9M functions,
we performed ChIP-seq analyses of Hht3-K9M and Clr4 (Fig-
ure 1B). In wild-type cells, Hht3 is broadly distributed across
the genome, with the only exception being at the centromeric re-
gions, in which histone H3 is replaced with a histone-variant
CENP-A. Clr4 is mainly localized at pericentric regions, where
many repetitive elements are present and H3K9me3 levels are
high (Figure 1A). The localization pattern of Hht3-K9M is similar
to that of wild-type Hht3 (Figure 1A), indicating that the mutation
has little effect on the incorporation of histone H3 into chromatin.
In hht3-K9M cells, Clr4 is still mainly enriched at pericentric re-
peats but with higher levels than found in wild-type cells (Fig-
ure 1B). ChIP-qPCR analyses of Clr4 and H3, using a
strain expressing FLAG-Clr4 and Hht3-GFP, confirm that Clr4
levels increase at pericentric dh repeats, but not at euchromatic
act1 locus in hht3-K9M cells (Figure 1C). Apparently, the broad
distribution of Hht3-K9M does not result in the redistribution of
Clr4 across the genome, suggesting that the intrinsic affinity be-
tween Clr4 and H3K9M alone is insufficient to sequester Clr4 on
chromatin, but additional mechanisms promote the sequestra-
tion of Clr4 at pericentric repeats by H3K9M.
The recent identification of CLRC as an E3 ubiquitin ligase of
H3K14ub and the association of H3K14ub with heterochromatin
(Oya et al., 2019; Stirpe et al., 2020) prompted us to check
whether H3K14ub promotes the sequestration of Clr4 by
H3K9M (Figure 2A). Interestingly, ChIP analyses show that Clr4
sequestration at pericentric repeats is abolished in rik1D hht3-
K9M, raf1D hht3-K9M, and raf2D hht3-K9M cells (Figure 2B),
suggesting that CLRC-mediated H3K14 ubiquitylation might
indeed contribute to the sequestration of Clr4 at pericentric re-
peats. The complete loss of Clr4 at pericentric repeats is due
to the fact that CLRC is critical for H3K9me3 and that
H3K9me3 reinforces the localization of Clr4 through the interac-
tion of H3K9me3 with the chromodomain of Clr4 (Zhang et al.,
2008).
CLRC is targeted to repetitive DNA elements through the RNA
interference (RNAi) pathway (Grewal and Jia, 2007) (Figure S1A).
ChIP analyses show that Clr4 is not sequestered at pericentric
repeats in hht3-K9M dcr1D, hht3-K9M ago1D, and hht3-K9M
chp1D cells (Figure S1B). In contrast, the sequestration of Clr4
by H3K9M is independent of Swi6 (Figure S1B), which is an
HP1 family protein essential for heterochromatin integrity but
which functions downstream of CLRC.
To further test the requirement for H3K14ub in the sequestration
of Clr4 by H3K9M, we generated an hht3-K9MK14R mutation,
which abolishes K14 ubiquitylation selectively on H3-containing
K9M. Western blot analyses show that Hht3-K9MK14R and
Hht3-K9M are expressed at similar levels (Figure 2C). ChIP ana-
lyses show that Clr4 levels at pericentric dh repeats in hht3-
K9MK14R cells are reduced to wild-type levels (Figure 2D).
We, then, further examined the effects of H3K9MK14R on het-
erochromatin function. Cells containing hht3-K9M are defective
in the silencing of an otr::ura4+ reporter gene inserted at the peri-
centric repeats, leading to the robust growth of cells on medium
without uracil and little growth on medium containing 5-FOA (flu-
oroorotic acid) (Figure 2E). These cells also lost H3K9me3 at
A C
B
Figure 1. The selective sequestration of Clr4 at pericentric repeats by H3K9M
(A) Western blot of fission yeast cell extract with a H3 antibody. A non-specific band serves as a loading control.
(B) ChIP-seq analyses of Hht3 and Clr4 levels across the fission yeast genome. H3K9me3 data are derived from Shan et al., 2016. Diagrams of the three
chromosomes are shown on top, with key positions, such as centromeres and telomeres, labeled as red circles. The region surrounding centromere I is enlarged
and shown on the right. The white box indicates CENP-A containing chromatin, and the red arrows indicate pericentric heterochromatin in which H3K9me3 and
Clr4 are enriched.
(C) ChIP analyses of FLAG-Clr4 and Hht3-GFP levels at pericentric dh repeats and act1+. Data are presented as means ± SD of three technical replicates.
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OPEN ACCESSpericentric dh repeats, accompanied by the accumulation of dh
RNA transcripts (Figures 2F and 2G). In hht3-K9MK14R cells, the
silencing of otr::ura4+ is similar to that in wild-type cells (Fig-
ure 2E). Moreover, H3K9me3 levels at pericentric dh repeats
and dh RNA levels in hht3-K9MK14R cells are similar to those
in wild-type cells (Figures 2F and 2G). Furthermore, ChIP-seq
analysis shows that H3K9me3 levels are restored at all major het-
erochromatin domains in hht3-K9MK14R cells (Figure 2H). In
contrast, hht1-K14R hht3-K9M cells are still defective in the
silencing of otr::ura4+, consistent with the fact that H3K14ub
function in cis to regulate the activity of Clr4 on H3K9 (Oya
et al., 2019; Stirpe et al., 2020) (Figures S1C and S1D).
To examine the effects of H3K14ub on the interaction between
H3K9M and Clr4, we generated histone tail peptides containing
ubiquitin mimics at H3K14. We synthesized biotin-tagged his-tone H3 tail peptides containing H3K14C and generated recom-
binant Ub-G76C. We then crosslinked the cysteines with 1,3 di-
chloroacetone (DCA) (Long et al., 2014) and purified the resulting
peptides containing ubiquitin mimics at H3K14 to homogeneity
(Figures 3A and S2). Peptide pull-down assays with recombinant
Clr4 SET domain (residue 190–490) show that H3K9MK14ub in-
teracts more strongly with Clr4 compared with H3K14C,
H3K9MK14C, or H3K14ub in the presence of S-adenosyl-methi-
onine (SAM) (Figure 3B). In addition, thermal shift assays also
show that H3K9MK14ub interacts with Clr4 in the presence of
SAM (Figure S3A), and Clr4 and H3K9MK14ub form a complex
in the presence of SAM in a gel-filtration assay (Figures S3G
and S3H). In the absence of SAM, H3K9MK14ub also results in
a thermal shift of Clr4, although the shift is smaller than that






Figure 2. The requirement of CLRC-mediated H3K14ub for the sequestration of Clr4 by H3K9M at heterochromatin in vivo
(A) Schematic diagram of CLRC in regulating H3K14ub and H3K9 methylation.
(B and D) ChIP analysis of FLAG-Clr4 levels at pericentric dh repeats, normalized to act1+. Data are presented as means ± SD of three technical replicates.
(C) Western blot analysis of Hht3 and Clr4 levels. Tubulin is used as loading control.
(E) Top, schematic diagram of the otr::ura4+ reporter. Bottom, serial dilution analysis of indicated strains to measure the expression of otr::ura4+.
(F) ChIP analysis of H3K9me3 levels at pericentric dh repeats, normalized to act1+. Data are presented as means ± SD of three technical replicates.
(G) qRT-PCR analysis of pericentric dh repeats, normalized to act1+. Data are presented as mean ± SD of 3 technical replicates.
(H) ChIP-seq analyses of H3K9me3 levels across the fission yeast genome in cells expressing H3K9MK14R.
See also Figure S1.
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OPEN ACCESSH3K14ub results in an intermediate thermal shift of Clr4 in the
absence of SAM, which is not observed in the presence of
SAM. This is likely because the combination of Clr4, H3K14ub,
and SAM results in H3K9 methylation reaction, which might
lead to the dissociation of the complex. We also noticed that
the addition of SAM alone, without peptide, results in greater
thermal stability of Clr4, which might explain why SAM is impor-
tant for binding (Figure S3C).
We further used bio-layer interferometry (BLI) to quantify the in-
teractions (Figure 3C). In the presence of SAM, the equilibrium
dissociation constant (KD) of the Clr4-SET interaction with
H3K9MK14C, H3K14ub, and H3K9MK14ub is 1.42 mM, 0.61 mM,
and 0.34 mM, respectively, whereas the KD of the Clr4 interaction
with H3K14C is below detection. Comparing H3K9MK14C with
H3K9MK14ub, kon increases from 50,770 M
1s1 to 118,4004 Cell Reports 35, 109137, May 18, 2021M1s1, whereas koffdecreases from0.0723 s
1 to 0.0405 s1, re-
sulting in t1/2 changes from9.6 to17.1 s.These results suggest that
thepresenceofH3K14ub increases theassociationbut decreases
the dissociation of Clr4 with H3K9M. Comparing H3K14ub and
H3K9MK14ub, the association rate kon decreases from 228,900
M1s1 to 118,400 M1s1, whereas the dissociate rate koff de-
creases from 0.1410 s1 to 0.0405 s1, resulting in t1/2 changes
from 4.9 to 17.1 s. These results suggest that, in the presence of
H3K14ub, it is more difficult for Clr4 to get on to H3K9M than on
to H3K9. Once Clr4 is bound to H3K9M, it is also more difficult
for Clr4 to get off.
In the absence of SAM, Clr4-SET interaction with H3K14ub is
mildly reduced (KD increased from 0.61 mM to 1.02 mM), but the
interaction between Clr4-SET and H3K9MK14ub is reduced





Figure 3. H3K14ub enhances the interaction between Clr4 and H3K9M
(A) SDS-PAGE analysis of peptides used. The gel is stained with Coomassie blue.
(B) SDS-PAGE analysis of Clr4-SET bound to different peptides as well as the corresponding flow-through fractions. The gel is stained with Coomassie blue.
(C) BLI analyses of the interaction of Clr4-SET with different histone H3-tail peptides.
(D) ChIP analysis of FLAG-TetR-Clr4-SET levels at tetO at different time points after the addition of tetracycline, normalized to act1+. Data are presented asmeans
± SD of three technical replicates.
(E) In vitro histone methyltransferase assays using Clr4-SET, 3H-SAM, H3-tail peptide, and the indicated amounts of H3K9M or H3K9MK14ub peptides. The
reaction product is resolved by SDS-PAGE, stained with Coomassie blue (bottom), and processed for fluorography (top).
(F) In vitro histone methyltransferase assays using Clr4-SET, SAM, H3-tail peptide, and varying amounts of H3K9M or H3K9MK14ub peptides. The concentration
of methylation reaction product S-adenosyl-homocysteine (SAH) wasmeasured by luminescence levels (RLUs, relative light units) after being processed with the
MTase Glo assay kit. Data are presented as means ± SD of two technical replicates.
See also Figures S2–S4.
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OPEN ACCESS(Figure S4A). SAM mainly affects the kon of Clr4-SET and
H3K9MK14ub interaction (1189,400 M1s1 and 23,550
M1s1 in the presence and absence of SAM, respectively), sug-
gesting that the presence of SAM helps Clr4 recognize the
H3K9M mutation.
To examine whether the presence of H3K9M slows down the
turnover of Clr4 on chromatin in vivo, we used a strain in which
Clr4 is targeted to 10 copies of the tetO binding sites through a
TetR-Clr4 fusionprotein (Figure 3D),which results in the formation
of a large, ectopic heterochromatin domain. This ectopic hetero-
chromatin also depends on every component of CLRC (Raguna-
than et al., 2015). ChIP analyses show that the addition of tetracy-
cline results in the quick release of Clr4 fromchromatin, withmost
TetR-Clr4 released from the tetO sites within 5 min of tetracycline
addition (Figure 3D). Inhht3-K9M cells,weobserved adelay in the
release of TetR-Clr4 (Figure 3D), suggesting that the presence ofH3K9M-containing nucleosomes, indeed, slows down the turn-
over of Clr4 on chromatin. In both hht3-K9M rik1D and hht3-
K9MK14R cells, the release of TetR-Clr4 is similar to the rate in
wild-type cells, suggesting that H3K14ub contributes to the
slow turnover of Clr4 on chromatin in hht3-K9M cells (Figure 3D).
We also examined whether the presence of H3K14ub en-
hances the inhibitory effects of H3K9MonClr4 enzymatic activity
in vitro. Using a histone methyltransferase assay with recombi-
nant Clr4 SET domain (190–490), 3H-labeled SAM as the methyl
donor, and histone H3 tail peptide as the substrate, we found
that H3K9MK14ub is a more-potent inhibitor compared with
H3K9M (Figure 3E). A non-radioactive methyltransferase assay
that measures the production of S-adenosyl-homocysteine
also confirmed that conclusion (Figure 3F).
Hydrogen/deuteriumexchange coupled tomass spectrometry






Figure 4. The 3FA mutation comprised the interaction between Clr4 and H3K9MK14ub and relieved the sequestration of Clr4 by H3K9M
in vivo
(A) Structure representation of Clr4 based on PDB: 6BP4 (Iglesias et al., 2018). The three residues mutated in 3FA (F256, F310, and F427), SAM, and the H3
peptide are presented as stick models. The H3 peptide is modeled based on the Dim-5-H3 complex structure (PDB: 1PEG) (Zhang et al., 2003).
(B) SDS-PAGE analysis of Clr4 or Clr4-3FA bound to H3K9MK14ub as well as the corresponding flow-through fraction. The gel is stained with Coomassie blue.
(C) BLI analysis of the interaction of Clr4-3FA H3K9MK14ub peptide.
(D) In vitro histone methyltransferase assays were performed with Clr4-SET, 3H-SAM, H3 tail peptide, and indicated amounts of H3K9M or H3K9MK14ub
peptides.
(E) In vitro histone methyltransferase assays were performedwith Clr4-SET, SAM, H3 peptide, and varying amounts of H3K9MK14ub peptides. The production of
SAH was measured by luminescence levels after being processed with MTase Glo assay kit. Data are presented as means ± SD of two technical replicates.
(F) ChIP analysis of FLAG-TetR-Clr4 levels at pericentric tetO, normalized to act1+. Data are presented as means ± SD of three technical replicates.
(G) ChIP analysis of FLAG-Clr4 levels at pericentric dh repeats, normalized to act1+. Data are presented as means ± SD of three technical replicates.
(H) A model for the selective sequestration of Clr4 by H3K9M at pericentric repeats.
See also Figures S3 and S4.
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OPEN ACCESSmediated by a hydrophobic surface of Clr4 that includes residues
F256, F310, and F427 (Stirpe et al., 2020) (Figure 4A). We gener-
ated a recombinant Clr4 SET domain containing the F256A,
F310A, and F427A mutations (3FA). That mutation strongly
reduced the interaction between Clr4 and H3K14ub and has little
effect on the structure of Clr4 (Stirpe et al., 2020). Peptide pull-
down assays, thermal-shift assays, and BLI, all demonstrate
that the 3FA mutation strongly reduces the interaction between
Clr4 and H3K9MK14ub, either in the presence or in the absence
of SAM (Figures 4B, 4C, S3D–S3F, S4B, and S4C). In addition,
in vitro histone methyltransferase assays show that the 3FA
mutant is less sensitive to H3K9MK14ub compared with that of6 Cell Reports 35, 109137, May 18, 2021wild-typeClr4 (Figures 4Dand4E), suggesting that the interaction
ofClr4withH3K14ub is critical for the inhibitory effects ofH3K9M.
To test the effects of 3FA on the sequestration of Clr4 by H3K9M
in vivo, we generated a strain expressing TetR-Clr4-3FA. ChIP
analyses show that TetR-Clr4-3FA is quickly released from the
tetO locus in both wild-type and hht3-K9M cells (Figure 4F), sug-
gesting that Clr4-3FA is not sequestered by H3K9M. We also
used a strain expressing Clr4-3FA at its endogenous chromo-
somal locus. In hht3-K9M cells, the sequestration of Clr4-3FA
mutant at pericentric repeats is abolished compared with that
of wild-type Clr4 (Figure 4G). Again, the complete loss of Clr4-
3FA at pericentric repeats is likely due to the requirement of
Report
ll
OPEN ACCESSH3K9me3 for the stable association of Clr4 at those regions,
given the effect of Clr4-3FA on H3K9me3 in vivo (Stirpe et al.,
2020). These results demonstrate that reducing the interaction
between Clr4 and H3K9MK14ub decreases the inhibitory effects
of H3K9MonClr4 enzymatic activity and compromises the ability
of H3K9M to sequester Clr4 on chromatin.
Altogether, our results suggest that the affinity between Clr4
and H3K9M is low, thus H3K9M by itself is insufficient to
sequester Clr4 on chromatin. At heterochromatin regions,
CLRC catalyzes the H3K14ub, which increases the affinity of
Clr4 to the H3 tail and enhances its enzymatic activity. H3K9M
synergizes with H3K14ub to interact with Clr4, leading to the se-
lective sequestration of Clr4 at heterochromatin. In euchromatin
regions, the absence of H3K14ub coupled with the lower kon of
Clr4 to H3K9M prevents Clr4 sequestration by H3K9M due to
the reduced ability of Clr4 to load on to H3K9M-containing nucle-
osomes (Figure 4H). In addition, our BLI data also highlights the
importance of protein-protein interaction kinetic properties,
which can be masked by affinity measurements, in regulating
biological processes.
One of the key discrepancies regarding the methyltransferase
sequestration model is in the case of H3.3K27M, in which most
foci with high levels of H3.3K27M show little enrichment of the
H3K27 methyltransferase PRC2 (Piunti et al., 2017). Although
the reason for such a discrepancy is complex (Fang et al.,
2018; Sarthy et al., 2020; Stafford et al., 2018), we speculate
that additional mechanisms at defined genomic locations might
change the kinetic properties of PRC2-H3.3K27M interactions,
leading to sequestration of PRC2 at selective loci. Indeed, in
H3.3K27M-expressing cells, PRC2 is sequestered at poised en-
hancers (Fang et al., 2018), and the H3.3K27M-PRC2 interac-
tions can be modulated by the presence of H3K27me3 (Diehl
et al., 2019; Stafford et al., 2018). In addition, although
H3K27M enhances the interaction between PRC2 and the H3
tail peptide, it has a minor role in the interaction between
PRC2 and the nucleosome (Wang et al., 2017), which is consis-
tent with the idea that H3K27M alone is insufficient to sequester
PRC2. Interestingly, structural analysis shows that the associa-
tion of PRC2 with nucleosome is regulated by JARID2-AEBP2
and H2AK119ub (Kasinath et al., 2021). It would be interesting
to examine whether H2AK119ub promotes the sequestration of
PRC2 by H3K27M, similar to the effects of H3K14ub on the
sequestration of Clr4 by H3K9M.
Similar to CLRC in fission yeast, the Neurospora crassa H3K9
methyltransferase Dim-5 and mammalian H3K9 methyltransfer-
ase SUV39H1 also associate with CUL4-based E3 ubiquitin
ligase complexes (Lewis et al., 2010; Yang et al., 2015). In both
organisms, CUL4, its adaptor protein DDB1, and the associated
DCAFs (DDB1 and CUL4-associated factors) are also required
for H3K9 methylation (Higa et al., 2006; Lewis et al., 2010; Xu
et al., 2010; Zhao et al., 2010). Although mammalian CUL4-
DDB1 complex ubiquitylates histone H3 in vitro (Wang et al.,
2006), it remains to be determined whether CUL4-DDB1 ubiqui-
tylates H3K14. H3K14ub stimulates the activity of mammalian
H3K9 methyltransferase SUV39H1 in vitro (Stirpe et al., 2020),
suggesting that the cross-talk between H3K14ub and
H3K9me3 might be conserved. H3K14ub is detected by mass
spectrometry analysis of mammalian histones (Kim et al.,2011). Therefore, it would be interesting to further examine
whether the crosstalk between H3K14ub and H3K9me is
conserved in higher organisms in vivo and howH3K14ub is regu-
lated during biological processes.
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MTase-Glo Methyltransferase Assay kit Promega V7601
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Oligonucleotides
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ForteBio Data analysis ForteBio v10.0.1.6
Samtools v1.2 Wellcome Trust Sanger Institute http://samtools.sourceforge.net/
GATK v3.5 Broad Institute, MIT https://github.com/broadinstitute/gatk/
releases
Bwa v0.7.12-r1039 Wellcome Trust Sanger Institute http://bio-bwa.sourceforge.net





Further information and request for resources and reagents should be directed to andwill be fulfilled by the Lead contact, Songtao Jia
(songtao.jia@columbia.edu).
Materials availability
The materials generated in this study is available upon request and will be shared without restriction.
Data and code availability
The accession number for the RNA-seq, MNase-seq, and ChIP-seq data reported in this paper are GEO: GSE159192.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
A list of yeast strains used is provided in Table S1. Yeast strains containing hht3-K9MK14R or hht1-K14Rwere generated by a PCR-
based module method. All other strains were published or constructed through genetic crosses.
METHOD DETAILS
Serial dilution analyses
For serial dilution plating assays, ten-fold dilutions of a mid log-phase culture were plated on the indicated medium and grown for
3 days at 30C.
Chromatin immunoprecipitation (ChIP) analyses
Log-phase yeast cells grown at 30C were incubated at 18C for 2 hours and then fixed for 30 minutes in 3% freshly made formal-
dehyde. The cells were pelleted and washed with PBS (phosphate-buffered saline) before resuspended in ChIP lysis buffer (50 mM
HEPES-KOH, pH 7.5, 140 mMNaCl, 1% Triton X-100, 0.1% Deoxycholate). Ice cold glass beads were added and the mixtures were
vigorously disrupted in a beadbeater. The lysates were collected and subjected to sonication to reduce chromatin size to 500-1000
base pairs (bp). The cleared cell lysates were incubated with Flag-agarose beads (Sigma) overnight at 4C. The beads were then
washed with ChIP lysis buffer twice, ChIP lysis buffer containing 0.5 M NaCl, Wash buffer (10 mM Tris, pH 8.0, 250 mM LiCl,
0.5% NP-40, 0.5% Deoxycholate, 1 mM EDTA), and TE (50 mM Tris pH 8.0, 1 mM EDTA). The bound chromatin fragments were
eluted with TES (50 mM Tris pH 8.0, 1 mM EDTA, 1% SDS), and the crosslinking was reversed by incubating at 65C overnight.
The protein DNAmixture was then subjected to proteinase K treatment and phenol:chloroform extraction before the DNAwas precip-
itated by ethanol.Cell Reports 35, 109137, May 18, 2021 e2
Report
ll
OPEN ACCESSFor TetR-Clr4 release, tetracycline was added to log-phase cultures at 30C to a final concentration of 10 mM and samples were
taken at 5, 10, and 20 minutes, fixed with 3% freshly made formaldehyde for 30 minutes at 18C.
Quantitative real-time PCR (qPCR) was performed with Maxima SYBR Green qPCR Master Mix (Fermentas) in a StepOne Plus
Real-Time PCR System (Applied Biosystems). DNA serial dilutions were used as templates to generate a standard curve of ampli-
fication for each pair of primers, and the relative concentration of the target sequence was calculated accordingly. An act1 fragment
was used as a reference to calculate the enrichment of ChIP over the whole-cell extract (WCE) for each target sequence. A list of DNA
oligos used is provided in the Key resources table.
ChIP-seq
DNA samples were prepared according to TruSeq ChIP sample preparation guide (Illumina) and sequenced on the Illumina HiSeq
2500 system by 100-bp paired-end sequencing. The raw reads were trimmed by Trimmomatic (v0.35) to remove remaining adaptor
contaminants and low-quality regions. The trimmed reads were aligned to the S. pombe reference genome (Ensembl assembly
version: ASM294v2.29) by bwa (v0.7.12-r1039) (http://bio-bwa.sourceforge.net/). The read-mapping files were further processed
by Samtools (v1.2) picard-tools (v2.0.1) (http://broadinstitute.github.io/picard/) andGATK (v3.5) for indexing, sorting, PCR duplicates
removal, and local-realignment around Indels. The per-based mapping depth was calculated by bedtools (v2.25.0) and the sliding
window analyses were further performed using a 100-bp window size and 50-bp step size. ChIP-seq data is available at GEO:
GSE159192.
ChIP-seq of H3K9me3 in hht3-K9MK14R cells
Log-phase yeast cells were crosslinked with 1% formaldehyde for 20 minutes with shaking at room temperature, followed by 5 mi-
nutes quenching with 125mM glycine. Cells were harvested, washed with PBS (phosphate-buffered saline) and flashfrozen with
liquid nitrogen. The thawed pellet was washed and then resuspended in ChIP lysis buffer (50 mM HEPES-KOH, pH 7.5,
140 mM NaCl, 1% Triton X-100, 0.1% Deoxycholate, 1mM PMSF). Ice-cold glass beads were added and the mixtures were vigor-
ously disrupted in a bead-beater with four 30 s rounds. The lysates were collected and NP buffer was added (10 mM Tris, pH 7.4,
1 M sorbitol, 50 mM NaCl, 5 mM MgCl2, 1 mM CaCl2). MNase was added to the reaction and the reactions were incubated at 37
C
for 20 minutes. MNase amount was titrated empirically so that the chromatin was digested to yield mainly mono- and di-nucleo-
somes. The reaction was stopped by the addition of 0.5 M EDTA, and the tubes were placed on ice. 5X ChIP lysis buffer was added
to the reaction, mixed by short vertexing, and the tubes were incubated on ice for 30 minutes. The reactions were then cleared by
centrifugation at 16,000 x g for 10 minutes. A small fraction of the cleared supernatant was reserved as input and the rest was used
for immunoprecipitation. The protocols for immunoprecipitation, reverse-crosslinking, and DNA precipitation are the same as in the
previous ChIP section. The precipitated DNA was treated with RNAase A (EN0531, Thermo Fisher Scientific) for 1 hour at 37C.
DNA concentration was determined with the Qubit dsDNA HS Assay Kit (Q33230, Thermo Fisher Scientific). 1-5 ng of ChIP and
input DNA were used for library construction using the NEBNext Ultra II DNA Library Prep Kit for Illumina (E7645, NEB). Libraries
were pooled and sequenced with single-end sequencing on a NextSeq500/550 at the JP Sulzberger Genome Center at Columbia
University.
Sequencing reads were de-multiplexed and aligned to the S. pombe reference genome (ASM294v2), obtained from Pombase
(Lock et al., 2019) with Bowtie2 using default parameters (Langmead and Salzberg, 2012). Genome-wide coverage was calculated
with deepTools2 (Ramı́rez et al., 2016) and normalized to counts per million (CPM). The coverage plot was visualized with IGV (Rob-
inson et al., 2011). ChIP-seq experiments were performed in duplicates for each genotype.
RNA analyses
Total cellular RNA was isolated from log-phase cells using MasterPure yeast RNA purification kit (Epicenter) according to the man-
ufacturer’s protocol. qRT-PCR analyses were performed with Power SYBRGreen RNA-to-CT 1-Step Kit (Thermo Fisher Scientific)
in a StepOne Plus Real-Time PCR System (Applied Biosystems). RNA serial dilutions were used as templates to generate a standard
curve of amplification for each pair of primers, and the relative concentration of the target sequence was calculated accordingly. An
act1 fragment served as a reference to normalize the concentration of samples. The concentration of each target gene in wild-type
cells was arbitrarily set to 1 and served as a reference for other samples. A list of DNA oligos used is provided in STAR Methods.
Western blot analyses
Cell lysates were prepared by lysing yeast cells with a beadbeater in ChIP lysis buffer. The lysates were sonicated for a total of 10 mi-
nutes to fragment chromatin. The cleared lysates were mixed with 2xSDS loading dye and resolved by SDS-PAGE. Western blot an-
alyses were performed with Flag (Sigma), GFP (Covance), and Tubulin antibodies.
Generation of peptides containing H3K14ub mimics
Histone H3 tail peptides with a C-terminal biotinylated lysine, H3K14C (residues 1–21, ARTKQTARKSTGGCAPRKQLAGGK-biotin)
and H3K9MK14C (ARTKQTARMSTG GCAPRKQLAGGK-biotin) were synthesized by Biomatik. Recombinant 6xHis tagged Ub-
G76Cwas purified from E.coli using Talon beads according to manufacturer’s protocol (Takara). Peptides and Ub-G76Cwere mixed
in a buffer of 50mMBorate pH 8.1, 2mMTCEP to a final concentration of 200 mMpeptide and 100 mMUb. Themixture was incubatede3 Cell Reports 35, 109137, May 18, 2021
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OPEN ACCESSat 37C for 30minutes and cool on ice for additional 30minutes. Freshly made DCAwas added to a final concentration of 100 mMand
the mixture was incubated on ice for 1 hour. The reaction is quenched by the addition of 5 mM mercaptoethanol.
The reaction mixture was first purified with an ULTRA-15ml centrifugal filter (10KDa cutoff, Amicon) to remove unreacted peptides
and self-ligated peptides, and then further purifiedwith Avidin agarose column (ThermoScientific). The columnwaswashedwith PBS
first, and then blocked with Biotin Blocking/Elution Buffer (2 mM D-biotin in PBS). After washing with Regeneration buffer (0.1M
glycine, pH 2.8) and PBS, samples were loaded onto the column, and the column was then washed with PBS. H3K14ub mimics
were eluted with Regeneration buffer.
Protein expression and purification
The SET domain of recombinant Clr4 (residues 190-490) and the 3FAmutant were cloned into a pET28a vector. The expression plas-
mids were transformed into Rosetta cells and protein expression was induced using 0.15mM isopropyl-1-thio-D-galactopyranoside.
After incubation overnight at 16C, the cells were harvested and resuspended in lysis buffer (50mMsodiumphosphate, 300mMNaCl,
pH 7.0), supplemented with 2 mM b-mercaptoethanol and lysed with ultrasonication. The lysate was incubated with Talon metal af-
finity resin (Takara Bio USA) and thenwashedwith lysis buffer containing 15mM imidazole. Bound protein was eluted with lysis buffer
containing 150 mM imidazole.
Peptide binding assays
Protein binding assays were performed by incubating recombinant proteins with biotinylated histone peptides in binding buffer
(10mM Tris, 150 mM NaCl, 1mM EDTA, 1mM DTT, 10 mM SAM, 0.05% NP-40) for one hour at 30C. Streptavidin beads were added
to isolate biotinylated peptide and associated proteins. The beads were washed four times in binding buffer. The proteins bound to
the beads were resolved by SDS-PAGE and stained with Coomassie blue.
Thermal shift assay
The thermal stability of the SET domain of clr4 with ligands was analyzed at various temperatures using theMx3005 PReal-Time PCR
system (Stratagene). Purified Clr4-SET or Clr4-SET-3FA mutant (3 mM) protein was incubated with 20 mM of H3K14C peptide,
H3K9MK14C, H3K14ub, or H3K9MK14ub, in the presences of 150 mMof SAM. All assays were performed in duplicate for each sam-
ple and contained final concentrations of 50 mM Tris (pH 8.0), 1 mM EDTA and 0.5 mM DTT. Reactions were first incubated at room
temperature for 10 minutes, then on ice for 10 minutes, and mixed with the fluorescence dye (SYPRO orange; Invitrogen). The tem-
perature was increased from 25 to 99 C in 1 C intervals over a 75-min period. Fluorescence values for each curve were normalized
to the maximum and the minimum of the curve.
Biolayer interferometry
BLI analyseswereperformed inblack 96-well plates (greinerbio-one,Germany) onanOctetRED96 instrument (ForteBio,USA). Prior to
use, biosensorswere soaked in assaybuffer (1XPBS, 0.01%NP-40, 0.5mMDTT, and0.2 ug/mlBSA) for 10min. BLI assays consisted
of six steps, all performed in the assay buffer: initial baseline (30 s), loading (120 s), and quenching (120 s), baseline (60 s), association
(30 s), and dissociation (90 s). Each biotinylated peptide (3 mg/ml) was immobilized on the Streptavidin biosensor tip during the loading
step. Toquench free streptavidin, 4mg/ml of biocytin (Sigma), abiotin analog,wasused.During theassociation step, analyte (Clr4-SET
WT or 3FA mutant) at various concentrations was diluted into the assay buffer. Biotinylated-peptide-loaded sensors itself was
measured as a control to subtract from experimental values before data processing. Sensorgrams were fit using global/1:1 binding
model by ForteBio Data analysis version 10.0.1.6, from which the equilibrium dissociation constant (Kd) and association (kon) and
dissociation (koff) rate constants were calculated. To measure the interaction in the presence of SAM, the assay buffer in all steps
was supplied with 10 mM SAM.
In vitro histone methyltransferase assays
Histone methyltransferase assays were performed with recombinant Clr4 SET domain (25 nM), histone H3 tail peptide (residue 1-21)
(1 mM) in histone methyltransferase buffer (10 mM Tris, pH 8.0, 1 mM EDTA, 1 mM DTT, 2 mM SAM) containing 3H-SAM (400 nM) for
30 minutes at 25C. The samples were resolved by SDS-PAGE and subjected to Coomassie staining to visualize the proteins and
then treated with EN3HANCE (Perkin Elmer) to visualize labeled substrates.
For non-radioactive histone methyltransferase assays, recombinant Clr4 SET domain (50 nM) were incubated histone H3 tail pep-
tide (residue 1-21) (10 mM) in histonemethyltransferase buffer (10mMTris, pH 8.0, 1mMEDTA, 1mMDTT, 10 mMSAM) for 60minutes
at 25C. The production of SAH was measured by the MTase-Glo Methyltransferase Assay kit according to the manufacture’s pro-
tocol. Luminescence was measured using a Synergy Neo2 Microplate reader (BioTek Instruments).
QUANTIFICATION AND STATISTICAL ANALYSIS
For ChIP-qPCR, qRT-PCR, and HMTase assays, data are presented asmean ± SDwith the number of technical replicates indicated.Cell Reports 35, 109137, May 18, 2021 e4
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Figure S1. The requirement of CLRC for the sequestration of Clr4 by H3K9M. (A) Schematic diagram of RNAi-mediated 
heterochromatin assembly at DNA repeats. (B) ChIP analysis of Flag-Clr4 levels at pericentric dh repeats, normalized to 
act1+. Data are presented as mean ± SD of three technical replicates. (C) Diagram of the mutations used. (D) Serial 











Figure S2. Diagram of the procedure used to synthesize and purify H3K14ub mimics. A SDS-PAGE of 






























































































































Figure S3. Clr4-SET and H3K9MK14ub forms a complex. (A-F) Thermal shift analyses of wild type Clr4-SET domain with 
indicated histone tail peptides or cofactor SAM. (G) Clr4-SET is incubated with a partially purified Ub-H3K9MK14C ligation 
mixture (containing H3K9MK14ub, Ub dimers (di-Ub) and free Ub) in the presence of SAM and then subject to gel filtration 






Clr4 vs H3K14ub Clr4 vs H3K9MK14ub
Clr4 vs H3K14C Clr4 vs H3K9MK14C
Figure S4. BLI analyses of indicated histone tail peptides with wild type Clr4-SET domain in the absence of 
SAM (A), with Clr4-3FA with in the presence SAM (B), and with Clr4-3FA in the absence of SAM (C). Related 
to Figures 3 and 4.
Clr4-3FA vs H3K14C Clr4-3FA vs H3K9MK14C
Clr4-3FA vs H3K14ub Clr4-3FA vs H3K9MK14ub


















Table S1. Yeast strains used in this study. Related to STAR Methods.
Name Genotype
BR172 Mat1Msmt0 leu1 his2 ura4 ade6-210 otr::ura4+
SPJ390 Mat1Msmt0 leu1 his2 ura4 ade6-210 otr::ura4+ Flag-clr4 
CS161 Mat1Msmt0 leu1 his2 ura4 ade6-210 otr::ura4+ Flag-clr4 hht3-K9M-GFP::kanMX6
SPJ4573 Mat1Msmt0 leu1 his2 ura4 ade6-210 hht3-Flag::hphMX6
CS170 Mat1Msmt0 leu1 his2 ura4 ade6-210 otr::ura4+ hht3-K9M-Flag::hphMX6
SPJ2922 Mat1Msmt0 leu1 his2 ura4 ade6-210 otr::ura4+ Flag-clr4 rik1∆::kanMX6
SPJ2926 Mat1Msmt0 leu1 his2 ura4 ade6-210 otr::ura4+ Flag-clr4 raf1∆::kanMX6
SPJ2924 Mat1Msmt0 leu1 his2 ura4 ade6-210 otr::ura4+ Flag-clr4 raf2∆::kanMX6
CS1225 Mat1Msmt0 leu1 his2 ura4 ade6-210 otr::ura4+ Flag-clr4 swi6∆::kanMX6
CS1205 Mat1Msmt0 leu1 his2 ura4 ade6-210 otr::ura4+ Flag-clr4 ago1∆::hphMX6
CS1212 Mat1Msmt0 leu1 his2 ura4 ade6-210 otr::ura4+ Flag-clr4 chp11∆::kanMX6
SPJ2871 Mat1Msmt0 leu1 his2 ura4 ade6-210 otr::ura4+ Flag-clr4 dcr1∆::kanMX6
CS161 Mat1Msmt0 leu1 his2 ura4 ade6-210 otr::ura4+ Flag-clr4 hht3-K9M-GFP::kanMX6
CS1218 Mat1Msmt0 leu1 his2 ura4 ade6-210 otr::ura4+ Flag-clr4 hht3-K9M-GFP::kanMX6 rik1∆::KanMX6
CS1214 Mat1Msmt0 leu1 his2 ura4 ade6-210 otr::ura4+ Flag-clr4 hht3-K9M-GFP::kanMX6 raf1∆::KanMX6
CS1207 Mat1Msmt0 leu1 his2 ura4 ade6-210 otr::ura4+ Flag-clr4 hht3-K9M-GFP::kanMX6 raf2∆::KanMX6
CS1222 Mat1Msmt0 leu1 his2 ura4 ade6-216 otr::ura4+ Flag-clr4 hht3-K9M-GFP::kanMX6 swi6∆::KanMX6
CS1202 Mat1Msmt0 leu1 his2 ura4 ade6-210 otr::ura4+ Flag-clr4 hht3-K9M-GFP::kanMX6 ago1∆::hphMX6
CS1209 Mat1Msmt0 leu1 his2 ura4 ade6-210 otr::ura4+ Flag-clr4 hht3-K9M-GFP::kanMX6 chp1∆::KanMX6
CS859 Mat1Msmt0 leu1 his2 ura4 ade6-210 otr::ura4+ Flag-clr4 hht3-K9M-GFP::kanMX6 dcr1∆::natMX6
CS483 Mat1Msmt0 leu1 his2 ura4 ade6-210 otr::ura4+ Flag-clr4 hht3-K9MK14R-GFP::kanMX6
CS534 Mat1Msmt0 leu1 his2 ura4 ade6-210 otr::ura4+ hht1-K14R-Flag::NatMX6
CS528 Mat1Msmt0 leu1 his2 ura4 ade6-210 otr::ura4+ hht1-K14R-Flag::NatMX6 hht3-K9M-Flag::hphMX6
YMF23 h+ leu1  ura4 ade6-210 ura4∆::10xtetO-ade6+ trp1::NatMX6-pclr4-TetR-2Flag-clr4-I
CS1929 h+ leu1  ura4 ade6-216 ura4∆::10xtetO-ade6+ trp1::NatMX6-pclr4-TetR-2Flag-clr4-I hht3-K9M-GFP::kanMX6 
CS2382
h+ leu1  ura4 ade6-210 ura4∆::10xtetO-ade6+ trp1::NatMX6-pclr4-TetR-2Flag-clr4-I hht3-K9MK14R-
GFP::kanMX6 
CS2387
h+ leu1  ura4 ade6-210 ura4∆::10xtetO-ade6+ trp1::NatMX6-pclr4-TetR-2Flag-clr4-I hht3-K9M-GFP::kanMX6 
rik1∆::kanMX6
CS2383 h+ leu1  ura4 ade6-210 ura4∆::10xtetO-ade6+ trp1::NatMX6-pclr4-TetR-2Flag-clr4-I-F256A/F310A/F427A
CS2403
h+ leu1  ura4 ade6-210 ura4∆::10xtetO-ade6+ trp1::NatMX6-pclr4-TetR-2Flag-clr4-I-F256A/F310A/F427A hht3-
K9M-GFP::kanMX6 
CS2414 h+ leu1  ura4 ade6-210 otr::ura4+ 3Flag-clr4-F256A/F310A/F427A
CS2412 h+ leu1  ura4 ade6-210 otr::ura4+ 3Flag-clr4-F256A/F310A/F427A hht3-K9M-Flag::hphMX6
